Recent attention has focused on fructose as having a unique role in the pathogenesis of cardiometabolic diseases.
T he adverse health effects of sugar have long been a matter of much public and scientific interest. For decades, it has been thought that a high intake of sugar is associated with the development of obesity, type 2 diabetes, and cardiovascular disease (CVD). Given the distinct metabolic fates that differentiate fructose from glucose, recent attention has focused on fructose as having a unique role in the etiology of these conditions. Fructose is found in sucrose or common table sugar, which is a disaccharide composed of 1 glucose molecule and 1 fructose molecule linked via an a1-4 glycoside bond, and is obtained from either sugar cane or beets. Fructose and glucose are also both found as naturally occurring monosaccharides that exist in fruit, honey, and some vegeta- HFCS-55 has the sweetness equivalent of sucrose and is widely used to flavor carbonated soft drinks. HFCS-42 is somewhat less sweet and is mainly used in processed foods including canned foods (e.g., soups and fruits), cereals, baked goods, desserts, sweetened dairy products, condiments, fruit-flavored noncarbonated beverages, candies, and many fast food items.
On the basis of national survey data from the United States, mean intake of total fructose as a percentage of total energy increased from 8.1% in 1978 to 9.1% in 2004, with greater increases observed in adolescents and young adults (1) . It is important to note that this increase was due to increases in fructose from sugars and sweeteners and not from naturally occurring fructose in fruit. With the exception of children 1 to 3 years of age, the estimated intake of naturally occurring fructose decreased from 11 to 16 g/day in 1978 to 7 to 9 g/day in 2004 for all age groups, representing an overall decrease of 3 to 7 g/day (1) .
Because we rarely consume fructose in isolation, the major source of fructose in the diet comes from fructose-containing sugars (sucrose and HFCS) largely in the form of added sugar (i.e., those sugars that are added to foods and beverages during processing and preparation). As a result, glucose intake tends to covary with fructose intake, and epidemiological studies cannot completely differentiate between the effects of fructose per se and those specifically attributable to glucose.
Time-trend data over the past 3 to 4 decades have shown a close parallel between the rise in added sugar intake and the obesity and diabetes epidemics in the United States (2) . Largely driving these trends has been the dramatic increase in the consumption of sugar-sweetened beverages (SSBs), which are the single greatest source of calories and added sugars in the U.S. diet, accounting for nearly one-half of all added sugar intake (3) ( Table 1) . One 360-ml can of regular soda contains about 35 g of sugar (140 calories) or 7% of total calories (on the basis of 2,000 kcal/ day) (4) . In the United States, SSBs are primarily sweetened with HFCS, whereas in Europe sucrose is the predominant sweetener.
Consumption of SSBs thus accounts for the majority of total fructose intake in the diet, either from sucrose or HFCS, and in this regard, relations between SSB and cardiometabolic diseases reflect potential effects of fructose and glucose or unique metabolic effects of fructose alone in epidemiologic studies ( Table 2) .
Although consumption of SSBs and added sugar appear to have decreased modestly in the past decade (4), data from NHANES (National Health and Nutrition Examination Survey) show that one-half of the U.S. population consumes SSBs on a given day, with 1 in 4 obtaining at least 200 calories from these beverages and 5% obtaining at least 567 calories-equivalent to 4 cans of soda (5) . These values exceed American Heart Association recommendations for no more than 100 to 150 kcal/day from all added sugar for most adults as well as recommendations from the World Health Organization and the 2015 Dietary Guidelines Advisory Committee to limit intake of added sugars to no more than 10% of energy.
Over the past decade, a large body of evidence has accumulated that shows a strong association between SSBs and obesity and related chronic diseases (6) (7) (8) .
For this reason and because they provide "empty" should be taken on the basis of existing evidence. In this review, we provide a brief overview of fructose metabolism and summarize the epidemiological evidence evaluating the relationship among fructose, obesity, diabetes, and cardiovascular risk in adults, focusing on fructose-containing beverages or SSBs, because they are the most abundant and wellcharacterized source of fructose in the diet. We also discuss biological mechanisms underlying these associations with an emphasis on the role of fructose.
Finally, we discuss healthier alternatives to SSBs and strategies to reduce SSB intake.
FRUCTOSE METABOLISM
Fructose metabolism differs from that of glucose in 2 major ways. First, there is nearly complete hepatic extraction of fructose, and second, as shown in Fructose is absorbed from the gut into the portal vein and is metabolized in the liver, where it is converted into fructose-1-phosphate by the enzyme fructokinase. Fructose-1-phosphate is then split into 2 3-carbon molecules, namely glyceraldehyde and Of particular note, unlike glucose, fructose can bypass the main rate limiting step of glycolysis at the level of phosphofructokinase, allowing it to act as a substrate for hepatic de novo lipogenesis and production of lipids. Thus, intake of fructose in high amounts can promote triglyceride synthesis from unchecked pathways. The actual amount of fructose needed to increase blood triglyceride levels is debated (9) . Significant increases in post-prandial triglycerides have been shown in response to consumption of 25% of energy from fructose and HFCS, but not glucose (10) . Recent data has also shown that consuming HFCS-sweetened beverages containing 10% to 25% of energy produced significant linear increases in postprandial triglycerides, suggesting a dose-response relationship between fructose consumption and increases in triglycerides (11) . Because added sugar intake in the United States constitutes about 14.9% of energy, with 71% of the population consuming $10% energy from added sugar (4), these effects of fructose are relevant to usual consumption patterns.
The massive uptake and phosphorylation of fructose in the liver can also deplete intracellular adenosine triphosphate, leading to an increase in uric acid production, which has been shown to induce meta- 
Fructose
Fructose is found in: sucrose, a disaccharide composed of 1 glucose molecule and 1 fructose molecule; HFCS, containing relatively equal amounts of glucose; and fruit, honey, and some vegetables as a naturally occurring monosaccharide. The major source of fructose in the diet comes from fructosecontaining sugars (sucrose and HFCS) that are added to foods and beverages and contain relatively equal amounts of glucose. Thus, intakes of glucose and fructose covary, and epidemiological studies cannot completely differentiate between their effects.
HFCS HFCS is produced from corn starch through industrial processing. The most common forms contain 42% or 55% fructose along with glucose and water.
Use of HFCS has progressively replaced the use of sugar in the United States due to its low cost. HFCS is the primary sweetener used in SSBs in the United States and in many processed foods.
SSBs
SSBs include soft drinks, fruit drinks, and energy drinks that are sweetened by HFCS or sucrose, which are added to the beverages by manufacturers, establishments, or individuals. SSBs are the greatest source of fructose-containing sugars in the diet and thus account for the majority of total fructose intake.
Relations between SSB and cardiometabolic diseases reflect the potential effects of fructose and glucose or unique metabolic effects of fructose alone in epidemiological studies.
HFCS ¼ high fructose corn syrup; SSB ¼ sugar-sweetened beverage.
FIGURE 1 Fructose Metabolism in Liver Cells
Fructose Glucose GLUT2 GLUT2
Fructose Glucose
Fructokinase ATP ADP AMP Uric acid
Fatty acids implying that a genetic predisposition to obesity can be partly offset by healthier beverage choices.
OBESITY: RCTs
Compared with observational studies, evidence from RCTs is limited, and the majority of trials evaluate short-term effects of specific interventions on weight change rather than long-term patterns. In our recent meta-analysis of 5 trials including 292 adults, we found that adding SSBs to the diet significantly increased body weight (7) . Similarly, another meta-analysis of 7 RCTs found a significant dose-dependent increase in body weight when SSBs were added to participants' diets (12) . However, in their meta-analysis of another 8 trials aiming to reduce SSB consumption (for prevention of weight gain), there was no overall effect on BMI, but a significant benefit was observed among individuals who were initially overweight (12) . This meta-analysis included 2 large and rigorously conducted RCTs in children and adolescents (14, 15) , which have overcome many of the limitations of previous trials such as small sample sizes, short duration, lack of blinding, and poor compliance. Although the trial by
Ebbeling et al. (14) found that reducing SSBs had a significant benefit on BMI in the first year of the trial during active intervention, it did not find a significant between-group difference after an additional 1 year of follow-up without active intervention (14) . This finding actually supports rather than refutes a benefit of reducing SSB consumption on adolescent obesity, suggesting that to achieve long-term benefits, the intervention needs to be sustained over time. These studies provide strong evidence that decreasing consumption of SSBs significantly reduces weight gain and obesity in this age group.
TYPE 2 DIABETES
A growing body of evidence indicates that SSB con- These results indicate that the liquid versus solid forms of calories from sugars may affect metabolic diseases differently. Fructose in beverages is absorbed more quickly than fructose in whole foods such as fruit and vegetables, which are absorbed more slowly due to their fiber content and slow digestion. The rapid absorption of liquid fructose increases the rate of hepatic extraction of fructose, de novo lipogenesis, and production of lipids.
CARDIOVASCULAR RISK
There is increasing evidence that higher SSB con- (19) . In this study, intake of SSBs was also significantly associated with increased plasma concentrations of inflammatory cytokines (19) .
Recent evidence has also emerged linking intake of SSBs to increased risk of stroke. Among 84,085 women and 43,371 men in the Harvard cohorts followed for 28 and 22 years, respectively, $1 SSB serving/day was associated with a 16% increased risk of total stroke compared with no servings in multivariable-adjusted models including BMI (20) .
This association was attenuated and no longer statistically significant after adjusting for hypertension and diabetes, suggesting that these factors may be mediators. In the multiethnic cohort of 2,564 residents in Northern Manhattan followed for a mean of 10 years, daily soft drink consumption was associated with an increased risk of vascular events only in participants free of obesity, diabetes, and metabolic syndrome at baseline and adjusted for a number of factors including BMI and hypertension (21) . A Japanese cohort of 39,786 men and women followed for 18 years found significant positive associations between SSB intake and total and ischemic stroke in women but not in men in models adjusted for hypertension and diabetes (22) . Adjustment for BMI and total energy intake had little effect on estimates,
suggesting that these factors are not major mediators.
Intake of both added sugar and SSBs was associated with an increased risk for CVD mortality in an analysis of NHANES III Linked Mortality cohort data (4) . After a median of 14.6 years of follow-up, added sugar intake was associated with a 2-fold greater risk of CVD death comparing extreme quintiles of intake.
In contrast, an analysis from the National Institutes of
Health-AARP Diet and Health Study, a prospective cohort of older U.S. adults, found that intake of total fructose but not of added sugar was associated with a modest increase in risk of all-cause mortality in men and women (23) . However, total sugars from beverages including added sugar were positively associated with risk of all-cause, CVD, and other-cause mortality in women, whereas only fructose from beverages was positively associated with risk of allcause and CVD mortality in men. The authors suggest that the differential associations by sex may be due to hormonal and biological differences or different levels of dietary misreporting, but these results may be also due to chance.
FRUCTOSE, GOUT, AND OTHER

METABOLIC CONDITIONS
Regular consumption of SSBs has been associated with hyperuricemia as well as with gout, which is a Fructose and Cardiometabolic Health common form of inflammatory arthritis arising from deposition of uric acid in articular cartilage, in 2 large cohorts (24, 25) . In particular, higher consumption of both total and added fructose from SSBs was associated with increased risk of gout in a dose-response manner. Gout and hyperuricemia have been associated with hypertension, diabetes, metabolic syndrome, kidney disease, and CVD (26) . Consumption of SSBs has also been associated with development of albuminuria, a marker of early kidney damage; formation of kidney stones; and increased risk of chronic kidney disease (27, 28) . In the NHS II, sucrose consumption was associated with an increased risk of kidney stones (29) . Observational studies have also found that a higher intake of sucrose and fructose is associated with a higher frequency of gallstones (30) .
Individuals with either kidney disease or gallstones
have been shown to have elevated cardiovascular risk (31, 32) . The studies discussed in this section reported estimates that were adjusted for BMI, suggesting that these associations are not completely dependent on body weight. 
RCTs
BIOLOGICAL MECHANISMS:
LIQUID CALORIES AND UNIQUE
METABOLIC EFFECTS OF FRUCTOSE
The prevailing mechanisms linking SSB intake to weight gain are decreased satiety and an incomplete compensatory reduction in energy intake at subsequent meals following ingestion of liquid calories (6) .
A typical 12 oz (360 ml) serving of soda contains on average 140 to 150 calories and 35 to 37.5 g of sugar.
If these calories are added to the typical diet without compensation for the additional calories, 1 can of soda/day could, in theory, lead to a weight gain of 5 lbs in 1 year. Short-term feeding studies comparing
SSBs with artificially sweetened beverages in relation to energy intake (36) and weight change (33, (36) (37) (38) (39) illustrate this point. Some limited evidence supporting incomplete compensation for liquid calories has also been provided by studies showing greater energy intake after isocaloric consumption of beverages compared with solid food (40, 41) . These studies argue that sugar or HFCS in liquid beverages may not suppress intake of solid foods to the level needed to maintain energy balance; however, the mechanisms responsible for this response are largely unknown.
SSBs may contribute to the development of diabetes and cardiovascular risk in part through caloric effects and the ability to induce weight gain, but also independently through noncalorically-related metabolic effects of constituent sugars (Central Illustration). Consumption of SSBs has been shown to induce rapid spikes in blood glucose and insulin levels (33) , which in combination with the large volumes consumed, contribute to a high dietary glycemic load (GL). High-GL diets are thought to stimulate appetite and promote weight gain due to the higher post-prandial insulin response following ingestion of a high-GL meal (42) and have been shown to promote hyperinsulinemia and insulin resistance (42) . High-GL diets have also been shown to exacerbate inflammatory biomarkers such as C-reactive protein (43) and
have been associated with an increased risk of diabetes (44) and CHD (18, 19) . SSBs may affect risk of CHD through effects on inflammation (45) , which influences atherosclerosis, plaque stability, and thrombosis (46) .
Intake of SSBs could stimulate an inflammatory
response through hyperglycemia, which can activate the electron transport chain to produce superoxide radicals (47) .
Some evidence suggests that consuming fructose from SSBs as a constituent of sucrose, and HFCS in Fructose has also been shown to promote the accumulation of visceral adipose tissue and the deposition of ectopic fat (48, 49) . A 10-week study comparing beverages providing 25% of energy from fructose with a beverage providing 25% of energy from glucose showed that fructose-containing beverages increased de novo lipogenesis and visceral adiposity, promoted dyslipidemia, and decreased insulin sensitivity compared with the glucose beverage (49) . Another study compared daily intakes of 1 l/day of cola, diet cola, milk, or water for 6 months and found that intake of cola increased liver fat, visceral fat, muscle fat, and triglycerides compared with the other beverages (50) . Fructose is also the only sugar known to increase serum uric acid levels, which is associated with the development of gout (51) . Hepatic uric acid production may also reduce endothelial nitric oxide, which may partly explain the association between SSB and CHD (52) . Fructose has also been shown to stimulate transcription of inflammatory factors by activating nuclear factor-kB in mice, further supporting inflammation as a Putative biological mechanisms linking excess sucrose and high fructose corn syrup intake from sugar-sweetened beverages (SSBs) to the development of obesity, gout, diabetes, and cardiovascular disease. Excess calories, incomplete compensation for liquid calories, and high glycemic load (GL) lead to obesity. Increased diabetes and cardiovascular disease risk also occur independently of weight through adverse glycemic effects and increased fructose metabolism in the liver. Excess fructose ingestion promotes hepatic uric acid production, de novo lipogenesis, and accumulation of visceral adiposity and ectopic fat, which ultimately increase diabetes and cardiovascular disease risk. ATP ¼ adenosine triphosphate. Fructose and Cardiometabolic Health potential pathway between SSB and CHD (53) . A recent meta-analysis found that fructose in isocaloric exchange with glucose increased total cholesterol, uric acid, and post-prandial triglycerides but had no adverse effect on other lipid parameters, insulin, or markers of nonalcoholic fatty liver disease and may be beneficial for body weight, blood pressure, and glycemic control (54) . As discussed by the authors, interpretation of these data was limited by the high dose range studied, negative comparators (glucose and starch), short follow-up, and methodological limitations of the available trials (54) . for added sugar. A combination of strategies across multiple levels is thus needed to reduce intake of SSBs, as illustrated in Table 3 . Implementing and evaluating these types of strategies on changes in consumers' purchasing and eating behaviors as well as health outcomes should be a high priority. 
HEALTHY-ALTERNATIVES TO SSBs
CONCLUSIONS
